Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
33.00
-0.04 (-0.12%)
Dec 29, 2025, 12:51 PM EST - Market open

Smith & Nephew Revenue

Smith & Nephew had revenue of $1.48B in the half year ending June 28, 2025, with 4.74% growth. This brings the company's revenue in the last twelve months to $5.94B, up 5.35% year-over-year. In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth.

Revenue (ttm)
$5.94B
Revenue Growth
+5.35%
P/S Ratio
2.36
Revenue / Employee
$329,125
Employees
18,060
Market Cap
14.00B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.81B261.00M4.70%
Dec 31, 20235.55B334.00M6.40%
Dec 31, 20225.22B3.00M0.06%
Dec 31, 20215.21B652.00M14.30%
Dec 31, 20204.56B-578.00M-11.25%
Dec 31, 20195.14B234.00M4.77%
Dec 31, 20184.90B139.00M2.92%
Dec 31, 20174.77B96.00M2.06%
Dec 31, 20164.67B35.00M0.76%
Dec 31, 20154.63B17.00M0.37%
Dec 31, 20144.62B266.00M6.11%
Dec 31, 20134.35B214.00M5.17%
Dec 31, 20124.14B-133.00M-3.11%
Dec 31, 20114.27B308.00M7.77%
Dec 31, 20103.96B190.00M5.04%
Dec 31, 20093.77B-29.00M-0.76%
Dec 31, 20083.80B432.00M12.82%
Dec 31, 20073.37B590.00M21.23%
Dec 31, 20062.78B227.00M8.89%
Dec 31, 20052.55B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings